Journal Article

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Gao, Wenli, Zhao, Qingwei, Xie, Huang, Li, Yongquan, Zhao, Xinyi, Lyu, Zhongyuan, Zhu, Chenyang

2024

Overview

Background Oritavancin is a new generation of semi-synthetic glycopeptide antibiotics against Gram-positive bacteria, which served as the first and only antibiotic with a single-dose therapeutic regimen to treat ABSSSI. A naturally occurring glycopeptide A82846B is the direct precursor of oritavancin. However, its application has been hampered by low yields and homologous impurities. This study established a multi-step combinatorial strategy to rationally construct a high-quality and high-efficiency biosynthesis system for A82846B and systematically optimize its fermentation process to break through the bottleneck of microbial fermentation production. Results Firstly, based on the genome sequencing and analysis, we deleted putative competitive pathways and constructed a better A82846B-producing strain with a cleaner metabolic background, increasing A82846B production from 92 to 174 mg/L. Subsequently, the PhiC31 integrase system was introduced based on the CRISPR-Cas12a system. Then, the fermentation level of A82846B was improved to 226 mg/L by over-expressing the pathway-specific regulator StrR via the constructed PhiC31 system. Furthermore, overexpressing glycosyl-synthesis gene evaE enhanced the production to 332 mg/L due to the great conversion of the intermediate to target product. Finally, the scale-up production of A82846B reached 725 mg/L in a 15 L fermenter under fermentation optimization, which is the highest reported yield of A82846B without the generation of homologous impurities. Conclusion Under approaches including blocking competitive pathways, inserting site-specific recombination system, overexpressing regulator, overexpressing glycosyl-synthesis gene and optimizing fermentation process, a multi-step combinatorial strategy for the high-level production of A82846B was developed, constructing a high-producing strain AO-6. The combinatorial strategies employed here can be widely applied to improve the fermentation level of other microbial secondary metabolites, providing a reference for constructing an efficient microbial cell factory for high-value natural products.

• Publisher: BioMed Central,BMC
• Subject: A82846B / Amycolatopsis - genetics / Amycolatopsis - metabolism / Anti-Bacterial Agents - biosynthesis / Applied Microbiology / Biosynthetic Pathways / Biosynthetic system / Biotechnology / Chemistry / Chemistry and Materials Science / Combinatorial strategies / CRISPR-Cas Systems / Enzymology / Fermentation / Fermentation optimization / Genetic Engineering / Glycopeptides - biosynthesis / Metabolic Engineering - methods / Microbial Genetics and Genomics / Microbiology / Oritavancin / Strain improvement